CN101732568B - Chinese medicinal oral liquid for treating cancer and preparation method thereof - Google Patents
Chinese medicinal oral liquid for treating cancer and preparation method thereof Download PDFInfo
- Publication number
- CN101732568B CN101732568B CN2008101602826A CN200810160282A CN101732568B CN 101732568 B CN101732568 B CN 101732568B CN 2008101602826 A CN2008101602826 A CN 2008101602826A CN 200810160282 A CN200810160282 A CN 200810160282A CN 101732568 B CN101732568 B CN 101732568B
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- herba
- fructus
- bletillae
- cayatiae japonicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal oral liquid for treating cancer and a preparation method thereof. The Chinese medicinal oral liquid comprises the following medicament raw materials: Japanese cayratia herb fruit, hairyvein agrimonia herb and bud, papaya, bletilla and immature bitter orange; the preparation method comprises the following steps: beating the Japanese cayratia herb fruit into slurry, processing the hairyvein agrimonia herb and bud, the papaya, the bletilla and the immature bitter orange into powder, stirring the powder in the Japanese cayratia herb fruit slurry, and filtering to prepare the oral liquid of the invention. The oral liquid of the invention has the advantages of simple and reasonable raw material composition, simple preparation process, low price, convenient administration, easy acceptance by patients, no toxic and side effect and good cancer treatment effect, and is a relatively ideal medicament for treating the cancer currently.
Description
Technical field: the invention belongs to medical technical scope, relate to a kind of medicine of treating cancer and preparation method thereof, particularly a kind of Chinese medicine oral liquid and preparation method thereof.
Background technology: in the prior art; The herbal species of treatment cancer is a lot; For example application number is 94107321.1; Name is called a kind of medicine of treating the medicine of tumor, and its raw material is made up of 39 flavor medical materials such as Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Codonopsis, Pheretima, Scolopendra, Squama Manis, Fructus Forsythiae, Bulbus Fritillariae Uninbracteatae, Fructus Amomi, Lignum Aquilariae Resinatum, Carapax Trionycis, Carapax et Plastrum Testudinis, Radix Notoginseng, Margarita, Rhizoma Curcumae, eupolyphaga, Poria, Rhizoma Corydalis, Radix Ginseng, Cinnabaris, Rhizoma Coptidis, Hirudo, Moschus, Cornu Cervi Pantotrichum, Radix Glycyrrhizae, Semen Ziziphi Spinosae, Fructus Crataegi, the Rhizoma Atractylodis Macrocephalae, the Radix Astragali, Periostracum Serpentis, Membrana Follicularis ovi, Flos Carthami, Agkistrodon, Fructus Solani Nigri, Cornu Saigae Tataricae, Impatientis, Herba Scutellariae Barbatae, watermelon crystal, Semen Armeniacae Amarum.Application number is 96114104.2; Name is called a kind of medicine of treating cancer, and raw material is made up of 15 flavor Chinese crude drugs such as chicken gall bladder, Semen Strychni (processed) powder, bilirubin, Venenum Bufonis, Radix Ginseng, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Herba Agrimoniae, Scolopendra, Scorpio, Herba Ephedrae, Herba Cistanches, Rhizoma Polygonati, Olibanum, Myrrha.Application number is 03156252.3; Name is called a kind of the treat medicine of cancer, the patent application of preparation method and its usage, its medicine by Herba Hylothelephii Verticillati, Herba Hedyotidis Diffusae, Fructus Crataegi, lobule stone network lotus, Herba Solani Nigri, Semen Coicis, Herba Scutellariae Barbatae, Herba Ardisiae Japonicae, Massa Medicata Fermentata, Rhizoma Paridis, the Rhizoma Atractylodis Macrocephalae, Poria, Pericarpium Citri Reticulatae, Cortex Lycii, Rhizoma Dioscoreae, Cornu Saigae Tataricae, Gekko Swinhonis, Radix Actinidiae Chinensis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Da Ye stone network lotus, Herba Houttuyniae, Herba Agrimoniae, Cortex Phellodendri, Rhizoma Polygonati, Rhizoma Corydalis totally 26 flavor Chinese medicines process.Can find out from last example, the medicine of existing treatment cancer, raw material variety is various mostly, and preparation technology is comparatively complicated, adds that some raw material is rare valuable medicinal, so that makes the price of medicine higher, and patient is difficult to bear.In addition, because some crude drug itself just has very big toxicity, so that makes medicine have certain toxicity, often patient is produced certain side effect.
Summary of the invention: the objective of the invention is for treatment for cancer provides a kind of Chinese medicine oral liquid new varieties of cancer and method of preparation thereof of treating, in order to overcome the above-mentioned drawback of existing in prior technology effectively.
According to the test of medium-height grass pharmacopeia and science, Herba Cayatiae Japonicae really contains 17 seed amino acids, monosaccharide of needed by human body etc., has the effect of kill cancer cell; Herba Agrimoniae has hemostasis, invigorates blood circulation, cold-blooded function; But the Fructus Chaenomelis depressed liver-energy dispersing and QI regulating, activating blood circulation to dissipate blood stasis; But Pseudobulbus Bletillae (Rhizoma Bletillae) granulation promoting is invigorated blood circulation; But the effect of Fructus Aurantii Immaturus removing mass circulation of qi promoting.The present invention is according to modern Chinese medicine theory and medical practice, and the pharmacological properties assembly of said herbal medicine material realization.
The raw material and the weight portion thereof of Chinese medicine oral liquid of the present invention consist of:
Herba Cayatiae Japonicae fruit 1000,
Herba Agrimoniae 80-120,
Fructus Chaenomelis 130-170,
Pseudobulbus Bletillae (Rhizoma Bletillae) 80-120,
Fructus Aurantii Immaturus 80-120.
Preferred raw material and weight portion thereof consist of:
Herba Cayatiae Japonicae fruit 1000,
Herba Agrimoniae 90-110,
Fructus Chaenomelis 140-160,
Pseudobulbus Bletillae (Rhizoma Bletillae) 90-110,
Fructus Aurantii Immaturus 90-110.
More preferred raw material and weight portion thereof consist of:
Herba Cayatiae Japonicae fruit 1000,
Herba Agrimoniae 95-105,
Fructus Chaenomelis 145-155,
Pseudobulbus Bletillae (Rhizoma Bletillae) 95-105,
Fructus Aurantii Immaturus 95-105.
Best raw material and weight portion thereof consist of:
Herba Cayatiae Japonicae fruit 1000,
Herba Agrimoniae 100,
Fructus Chaenomelis 150,
The Pseudobulbus Bletillae (Rhizoma Bletillae) 100,
Fructus Aurantii Immaturus 100.
Two, the method for preparing of Chinese medicine oral liquid of the present invention, its processing step is following:
(1) the Herba Cayatiae Japonicae fruit is processed into serosity with conventional method;
(2) with Herba Agrimoniae, Fructus Chaenomelis, the Pseudobulbus Bletillae (Rhizoma Bletillae) and Fructus Aurantii Immaturus four flavor Chinese crude drugs routine separately or together are processed into medicated powder;
(3) above-mentioned steps two is processed in medicated powder mix to the prepared Herba Cayatiae Japonicae pulp of above-mentioned step () liquid that makes, conventional thereafter the filtration promptly makes oral liquid of the present invention.
For making Herba Agrimoniae; Fructus Chaenomelis; The effective ingredient of the Pseudobulbus Bletillae (Rhizoma Bletillae) and Fructus Aurantii Immaturus four flavor Chinese crude drugs dissolves in the Herba Cayatiae Japonicae pulp liquid more fully; Conventional thereafter filtration the in the above-mentioned said step (three) is the Herba Cayatiae Japonicae pulp liquid that mix is had four flavor Chinese crude drug medicated powder such as Herba Agrimoniae, puts the conventional filtration of row again after 1-3 days.
Chinese medicine oral liquid of the present invention is a brown liquid, has stored deposition, and jolting is solvable loosing, and does not influence and drinks.Feeble QI is fragrant, and it is little sour-sweet to distinguish the flavor of.Main component has aminoacid, monosaccharide, reproducibility Ah's oligosaccharide, flavonoid, acidic materials, sterol, tannin etc.Airtight cryopreservation, the shelf-life can reach 2 years.Can be used for treating cancer, have blood fat reducing, arteriosclerosis, enhancing platelet and immune function of human body simultaneously, also have removing toxic substances and promoting subsidence of swelling, the diarrhea of heat type that disappears is wet, activating blood circulation to dissipate blood stasis, the effect that fills blood.No contraindication has no side effect, and ordinary person can drink, but obeys life lengthening for a long time.
Usage and consumption: oral, 3-4 time on the one, each 2 liang.
Chinese medicine oral liquid of the present invention, its raw material is formed advantages of simple, and preparation technology is simple, and price is low, and taking convenience is prone to accept for patient.Have no side effect, the treatment cancer is effective, is a kind of comparatively ideal medicine of present treatment of cancer.
The specific embodiment:
Embodiment 1: get Herba Cayatiae Japonicae fruit double centner, be broken into serosity with beater, place container; Get 10 kilograms of Herba Agrimoniaes, 15 kilograms of Fructus Chaenomeliss, 10 kilograms of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 10 kilograms of Fructus Aurantii Immaturuss, add pulverizer together and be ground into powder; Herba Agrimoniae, Fructus Chaenomelis, the Pseudobulbus Bletillae (Rhizoma Bletillae), the Fructus Aurantii Immaturus pulverized are added mix in the above-mentioned Herba Cayatiae Japonicae pulp liquid; Have the Herba Cayatiae Japonicae pulp liquid of Herba Agrimoniae, Fructus Chaenomelis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Aurantii Immaturus powder to put 3 days mix, carry out squeeze and filter, promptly make the diffusing article of Chinese medicine oral liquid of the present invention, the conventional fill of article of will loosing again promptly makes Chinese medicine oral liquid finished product of the present invention.
Embodiment 2: according to embodiment 1, and wherein 9.5 kilograms of Herba Agrimoniaes, 14.5 kilograms of Fructus Chaenomeliss, 10.5 kilograms of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 10.5 kilograms of Fructus Aurantii Immaturuss; The storing time is 2 days.
Embodiment 3: according to embodiment 1, and wherein 10.5 kilograms of Herba Agrimoniaes, 15.5 kilograms of Fructus Chaenomeliss, 9.5 kilograms of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 9.5 kilograms of Fructus Aurantii Immaturuss; The storing time is 2 days.
Embodiment 4: according to embodiment 1, and wherein 9 kilograms of Herba Agrimoniaes, 14 kilograms of Fructus Chaenomeliss, 11 kilograms of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 11 kilograms of Fructus Aurantii Immaturuss; The storing time is 1 day.
Embodiment 5: according to embodiment 1, and wherein 11 kilograms of Herba Agrimoniaes, 16 kilograms of Fructus Chaenomeliss, 9 kilograms of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 9 kilograms of Fructus Aurantii Immaturuss; The storing time is 1 day.
Case is introduced:
Lin Zhaode, male, 57 years old, Jiangsu Pizhou defense shut Ya village, early in 1990 by the Fourth People's Hospital of Xuzhou City diagnosed with liver cancer, liver tumors 3 × 3.5 mm, in January 1991 began taking oral present invention, 170 days, dry lumps disappear recovered.So far do not have recurrence, physical manifestations is healthy.
Luo Guiying, the woman, 46 years old, the brass hill people of Jiangsu Province, be diagnosed as hepatocarcinoma through Xuzhou City No.4 People's Hospital in February, 1997,2 * 2.6 millimeters of hepatoncus, begin to take oral liquid of the present invention in March, 97, and after 90 days, dried lump disappears and recovers.So far do not have recurrence, physical manifestations is healthy.
Sun Qinbin, the man, 48 years old, residential district township, Tancheng County, Shandong Province Lu Zhuan people, at the beginning of 2006 4 months, the inspection through the People's Hospital, Tancheng County is diagnosed as stomach early cancer cytopathy, and on April 26th, 2006 began to take oral liquid of the present invention, recovered after 130 days.So far do not have recurrence, physical manifestations is healthy.
Jiang Dengpo, man, 56 years old, Gang Shang town, Tancheng County, Shandong Province Jiang Zhuan people from village; Be diagnosed as pulmonary carcinoma late period in March, 2006 through the Linyi City the People's Hospital, 4.6 * 4.2 millimeters of lumps, begin in mid-March, 2006; Press special case and strengthen treatment, take oral liquid of the present invention, four times a day; Each three liang, took altogether 170 days, so far existence in spite of illness.
Old syphon, the man, 50 years old, He Gou town, Xinyi City, Jiangsu Province river people from village, be diagnosed as gastric cancer through Xuzhou City No.4 People's Hospital in February, 2007, and railway hospital surgical and chemotherapy are 5 times in the Xinyi.After this in August, 2007 recurrence, can't go chemotherapy again.On JIUYUE 5th, 2007 was taken oral liquid of the present invention, recovered in 80 days, did not have recurrence so far.
Claims (6)
1. a Chinese medicine oral liquid of treating cancer is characterized in that its raw material and weight portion thereof consist of: Herba Cayatiae Japonicae fruit 1000, Herba Agrimoniae 80-120, Fructus Chaenomelis 130-170, Pseudobulbus Bletillae (Rhizoma Bletillae) 80-120, Fructus Aurantii Immaturus 80-120.
2. the Chinese medicine oral liquid of treatment cancer according to claim 1 is characterized in that described raw material and weight portion thereof consist of: Herba Cayatiae Japonicae fruit 1000, Herba Agrimoniae 90-110, Fructus Chaenomelis 140-160, Pseudobulbus Bletillae (Rhizoma Bletillae) 90-110, Fructus Aurantii Immaturus 90-110.
3. the Chinese medicine oral liquid of treatment cancer according to claim 1 is characterized in that described raw material and weight portion thereof consist of: Herba Cayatiae Japonicae fruit 1000, Herba Agrimoniae 95-105, Fructus Chaenomelis 145-155, Pseudobulbus Bletillae (Rhizoma Bletillae) 95-105, Fructus Aurantii Immaturus 95-105.
4. the Chinese medicine oral liquid of treatment cancer according to claim 1 is characterized in that described raw material and weight portion thereof consist of: Herba Cayatiae Japonicae fruit 1000, Herba Agrimoniae 100, Fructus Chaenomelis 150, the Pseudobulbus Bletillae (Rhizoma Bletillae) 100, Fructus Aurantii Immaturus 100.
5. method for preparing according to the Chinese medicine oral liquid of the said treatment cancer of claim 1 is characterized in that processing step is following:
One, the Herba Cayatiae Japonicae fruit is processed into serosity with conventional method;
Two, with Herba Agrimoniae, Fructus Chaenomelis, the Pseudobulbus Bletillae (Rhizoma Bletillae) and Fructus Aurantii Immaturus four flavor Chinese crude drugs routine separately or together are processed into medicated powder;
Three, above-mentioned steps two is processed in medicated powder mix to the prepared Herba Cayatiae Japonicae pulp of the above-mentioned step 1 liquid that makes, conventional thereafter the filtration promptly makes oral liquid.
6. method for preparing according to claim 5 is characterized in that conventional thereafter filtration the in the said step 3, is the Herba Cayatiae Japonicae pulp liquid that mix is had four flavor Chinese crude drug medicated powder such as Herba Agrimoniae, puts the conventional filtration of row again after 1-3 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101602826A CN101732568B (en) | 2008-11-13 | 2008-11-13 | Chinese medicinal oral liquid for treating cancer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101602826A CN101732568B (en) | 2008-11-13 | 2008-11-13 | Chinese medicinal oral liquid for treating cancer and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101732568A CN101732568A (en) | 2010-06-16 |
| CN101732568B true CN101732568B (en) | 2012-04-11 |
Family
ID=42456936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101602826A Expired - Fee Related CN101732568B (en) | 2008-11-13 | 2008-11-13 | Chinese medicinal oral liquid for treating cancer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101732568B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585565A (en) * | 2013-05-13 | 2014-02-19 | 姚绍文 | Anticancer traditional Chinese medicine and preparation method |
-
2008
- 2008-11-13 CN CN2008101602826A patent/CN101732568B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101732568A (en) | 2010-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101347612B (en) | Compound medicament for treating common cold cough and acute/chronic bronchitis, and preparation method thereof | |
| CN101856430A (en) | Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN102274361A (en) | Anticancer medicinal composition and preparation method of decoction thereof | |
| CN102389554B (en) | Chinese medicinal formula capable of invigorating kidney yang and tonifying kidney yin as well as its product | |
| CN100536888C (en) | Traditional Chinese medicine preparation for treating chronic nephritis and nephrotic syndrome | |
| CN102488743B (en) | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation | |
| CN101940733B (en) | Traditional Chinese medicinal composition for curing nephritis diseases and preparation method thereof | |
| CN101926942A (en) | Glucose-lowering health care medicinal tea and preparation method thereof | |
| CN102698098B (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN101623446A (en) | Chinese medicinal composition for treating alopecia and premature graying of hair | |
| CN103083412A (en) | Traditional Chinese medicine for treating premature graying | |
| CN106692780B (en) | Composition for preventing and relieving diabetes and complications thereof | |
| CN102688445B (en) | Traditional Chinese medicine for treating diabetes and preparation method thereof | |
| CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN102698099B (en) | Pill for treating diabetes mellitus | |
| CN102671158B (en) | Traditional Chinese medicine for treating edema and preparation method of same | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN101732568B (en) | Chinese medicinal oral liquid for treating cancer and preparation method thereof | |
| CN101732455A (en) | Medicament for treating chronic hepatitis | |
| CN101167872B (en) | Medicinal composition for beautifying and face-nourishing and preparation method thereof | |
| CN103705731B (en) | A kind of Chinese medicine composition for the treatment of chronic alcoholic toxic liver disease | |
| CN101745043A (en) | Traditional Chinese medicine composite used for curing pregnant jaundice of newborn infant | |
| CN102671042A (en) | Traditional Chinese medicinal composition for treating acne and preparation method thereof | |
| CN102309725B (en) | Traditional Chinese medicine preparation for treating hepatitis B cirrhosis and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yin Qingshun Inventor after: Zhang Zhongjiao Inventor before: Zhang Zhongjiao |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG ZHONGJIAO TO: YIN QINGSHUN ZHANG ZHONGJIAO |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhongjiao Inventor after: Yin Qingshun Inventor before: Yin Qingshun Inventor before: Zhang Zhongjiao |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YIN QINGSHUN ZHANG ZHONGJIAO TO: ZHANG ZHONGJIAO YIN QINGSHUN |
|
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhongjiao Inventor before: Zhang Zhongjiao Inventor before: Yin Qingshun |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG ZHONGJIAO YIN QINGSHUN TO: ZHANG ZHONGJIAO |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120411 Termination date: 20151113 |